Report Detail

Pharma & Healthcare Global Butorphanol Market Research Report 2021

  • RnM4300851
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Butorphanol Market Overview

  • 1.1 Product Overview and Scope of Butorphanol
  • 1.2 Butorphanol Segment by Type
    • 1.2.1 Global Butorphanol Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Spray
    • 1.2.3 Injection
    • 1.2.4 Tablet
  • 1.3 Butorphanol Segment by Application
    • 1.3.1 Butorphanol Sales Comparison by Application: (2021-2027)
    • 1.3.2 Human
    • 1.3.3 Veterinary
  • 1.4 Global Butorphanol Market Size Estimates and Forecasts
    • 1.4.1 Global Butorphanol Revenue 2016-2027
    • 1.4.2 Global Butorphanol Sales 2016-2027
    • 1.4.3 Butorphanol Market Size by Region: 2016 Versus 2021 Versus 2027

2 Butorphanol Market Competition by Manufacturers

  • 2.1 Global Butorphanol Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Butorphanol Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Butorphanol Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Butorphanol Manufacturing Sites, Area Served, Product Type
  • 2.5 Butorphanol Market Competitive Situation and Trends
    • 2.5.1 Butorphanol Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Butorphanol Players Market Share by Revenue
    • 2.5.3 Global Butorphanol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Butorphanol Retrospective Market Scenario by Region

  • 3.1 Global Butorphanol Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Butorphanol Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Butorphanol Market Facts & Figures by Country
    • 3.3.1 North America Butorphanol Sales by Country
    • 3.3.2 North America Butorphanol Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Butorphanol Market Facts & Figures by Country
    • 3.4.1 Europe Butorphanol Sales by Country
    • 3.4.2 Europe Butorphanol Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Butorphanol Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Butorphanol Sales by Region
    • 3.5.2 Asia Pacific Butorphanol Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Butorphanol Market Facts & Figures by Country
    • 3.6.1 Latin America Butorphanol Sales by Country
    • 3.6.2 Latin America Butorphanol Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Butorphanol Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Butorphanol Sales by Country
    • 3.7.2 Middle East and Africa Butorphanol Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Butorphanol Historic Market Analysis by Type

  • 4.1 Global Butorphanol Sales Market Share by Type (2016-2021)
  • 4.2 Global Butorphanol Revenue Market Share by Type (2016-2021)
  • 4.3 Global Butorphanol Price by Type (2016-2021)

5 Global Butorphanol Historic Market Analysis by Application

  • 5.1 Global Butorphanol Sales Market Share by Application (2016-2021)
  • 5.2 Global Butorphanol Revenue Market Share by Application (2016-2021)
  • 5.3 Global Butorphanol Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Hikma Pharmaceuticals
    • 6.1.1 Hikma Pharmaceuticals Corporation Information
    • 6.1.2 Hikma Pharmaceuticals Description and Business Overview
    • 6.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Hikma Pharmaceuticals Product Portfolio
    • 6.1.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 6.2 Athanas Enterprise Private Limited
    • 6.2.1 Athanas Enterprise Private Limited Corporation Information
    • 6.2.2 Athanas Enterprise Private Limited Description and Business Overview
    • 6.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Athanas Enterprise Private Limited Product Portfolio
    • 6.2.5 Athanas Enterprise Private Limited Recent Developments/Updates
  • 6.3 Pfizer
    • 6.3.1 Pfizer Corporation Information
    • 6.3.2 Pfizer Description and Business Overview
    • 6.3.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Pfizer Product Portfolio
    • 6.3.5 Pfizer Recent Developments/Updates
  • 6.4 Apothecon Pharmaceuticals
    • 6.4.1 Apothecon Pharmaceuticals Corporation Information
    • 6.4.2 Apothecon Pharmaceuticals Description and Business Overview
    • 6.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Apothecon Pharmaceuticals Product Portfolio
    • 6.4.5 Apothecon Pharmaceuticals Recent Developments/Updates
  • 6.5 Mylan
    • 6.5.1 Mylan Corporation Information
    • 6.5.2 Mylan Description and Business Overview
    • 6.5.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Mylan Product Portfolio
    • 6.5.5 Mylan Recent Developments/Updates
  • 6.6 Novex Pharma
    • 6.6.1 Novex Pharma Corporation Information
    • 6.6.2 Novex Pharma Description and Business Overview
    • 6.6.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Novex Pharma Product Portfolio
    • 6.6.5 Novex Pharma Recent Developments/Updates
  • 6.7 Bristol Myers Squibb
    • 6.6.1 Bristol Myers Squibb Corporation Information
    • 6.6.2 Bristol Myers Squibb Description and Business Overview
    • 6.6.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bristol Myers Squibb Product Portfolio
    • 6.7.5 Bristol Myers Squibb Recent Developments/Updates
  • 6.8 Sanochemia Pharmazeutika
    • 6.8.1 Sanochemia Pharmazeutika Corporation Information
    • 6.8.2 Sanochemia Pharmazeutika Description and Business Overview
    • 6.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Sanochemia Pharmazeutika Product Portfolio
    • 6.8.5 Sanochemia Pharmazeutika Recent Developments/Updates
  • 6.9 Selectavet
    • 6.9.1 Selectavet Corporation Information
    • 6.9.2 Selectavet Description and Business Overview
    • 6.9.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Selectavet Product Portfolio
    • 6.9.5 Selectavet Recent Developments/Updates
  • 6.10 Richter Pharma Ag
    • 6.10.1 Richter Pharma Ag Corporation Information
    • 6.10.2 Richter Pharma Ag Description and Business Overview
    • 6.10.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Richter Pharma Ag Product Portfolio
    • 6.10.5 Richter Pharma Ag Recent Developments/Updates
  • 6.11 Troy Laboratories Nz
    • 6.11.1 Troy Laboratories Nz Corporation Information
    • 6.11.2 Troy Laboratories Nz Butorphanol Description and Business Overview
    • 6.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Troy Laboratories Nz Product Portfolio
    • 6.11.5 Troy Laboratories Nz Recent Developments/Updates
  • 6.12 Animedica
    • 6.12.1 Animedica Corporation Information
    • 6.12.2 Animedica Butorphanol Description and Business Overview
    • 6.12.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Animedica Product Portfolio
    • 6.12.5 Animedica Recent Developments/Updates
  • 6.13 Boehringer Ingelheim Santé Animale
    • 6.13.1 Boehringer Ingelheim Santé Animale Corporation Information
    • 6.13.2 Boehringer Ingelheim Santé Animale Butorphanol Description and Business Overview
    • 6.13.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Boehringer Ingelheim Santé Animale Product Portfolio
    • 6.13.5 Boehringer Ingelheim Santé Animale Recent Developments/Updates
  • 6.14 Ausrichter
    • 6.14.1 Ausrichter Corporation Information
    • 6.14.2 Ausrichter Butorphanol Description and Business Overview
    • 6.14.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Ausrichter Product Portfolio
    • 6.14.5 Ausrichter Recent Developments/Updates
  • 6.15 Zoetis
    • 6.15.1 Zoetis Corporation Information
    • 6.15.2 Zoetis Butorphanol Description and Business Overview
    • 6.15.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Zoetis Product Portfolio
    • 6.15.5 Zoetis Recent Developments/Updates
  • 6.16 Dechra Pharmaceuticals
    • 6.16.1 Dechra Pharmaceuticals Corporation Information
    • 6.16.2 Dechra Pharmaceuticals Butorphanol Description and Business Overview
    • 6.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Dechra Pharmaceuticals Product Portfolio
    • 6.16.5 Dechra Pharmaceuticals Recent Developments/Updates
  • 6.17 Faunapharma
    • 6.17.1 Faunapharma Corporation Information
    • 6.17.2 Faunapharma Butorphanol Description and Business Overview
    • 6.17.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Faunapharma Product Portfolio
    • 6.17.5 Faunapharma Recent Developments/Updates
  • 6.18 Merck KGaA
    • 6.18.1 Merck KGaA Corporation Information
    • 6.18.2 Merck KGaA Butorphanol Description and Business Overview
    • 6.18.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Merck KGaA Product Portfolio
    • 6.18.5 Merck KGaA Recent Developments/Updates

7 Butorphanol Manufacturing Cost Analysis

  • 7.1 Butorphanol Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Butorphanol
  • 7.4 Butorphanol Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Butorphanol Distributors List
  • 8.3 Butorphanol Customers

9 Butorphanol Market Dynamics

  • 9.1 Butorphanol Industry Trends
  • 9.2 Butorphanol Growth Drivers
  • 9.3 Butorphanol Market Challenges
  • 9.4 Butorphanol Market Restraints

10 Global Market Forecast

  • 10.1 Butorphanol Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Butorphanol by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Butorphanol by Type (2022-2027)
  • 10.2 Butorphanol Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Butorphanol by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Butorphanol by Application (2022-2027)
  • 10.3 Butorphanol Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Butorphanol by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Butorphanol by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Spray
    Injection
    Tablet

    Segment by Application
    Human
    Veterinary

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Hikma Pharmaceuticals
    Athanas Enterprise Private Limited
    Pfizer
    Apothecon Pharmaceuticals
    Mylan
    Novex Pharma
    Bristol Myers Squibb
    Sanochemia Pharmazeutika
    Selectavet
    Richter Pharma Ag
    Troy Laboratories Nz
    Animedica
    Boehringer Ingelheim Santé Animale
    Ausrichter
    Zoetis
    Dechra Pharmaceuticals
    Faunapharma
    Merck KGaA


    Summary:
    Get latest Market Research Reports on Butorphanol. Industry analysis & Market Report on Butorphanol is a syndicated market report, published as Global Butorphanol Market Research Report 2021. It is complete Research Study and Industry Analysis of Butorphanol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,108.83
    3,163.25
    4,217.67
    2,432.67
    3,649.00
    4,865.33
    317,445.60
    476,168.40
    634,891.20
    217,376.75
    326,065.13
    434,753.50
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report